New gel aims to fade melasma with fewer side effects

NCT ID NCT07530016

First seen May 05, 2026

Summary

This early study tests a new gel for melasma, a skin condition causing dark patches on the face. The gel combines three ingredients to lighten spots, reduce inflammation, and help absorption. Ten women aged 18-50 will apply the gel for 12 weeks to see if it improves their skin with fewer side effects than current treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANEXAMIC ACID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Melanosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.